... Center How Chemotherapy Drugs Work — American Cancer Society Targeted Therapy Drugs for Chronic Lymphocytic Leukemia — American Cancer Society Ibrutinib (Oral Route) — Mayo Clinic Label: Imbruvica — Ibrutinib Capsule — DailyMed Label: Calquence — Acalabrutinib Tablet, Film Coated — DailyMed Label: Brukinsa — Zanubrutinib Capsule — DailyMed Label: Jaypirca ...
... Center How Chemotherapy Drugs Work — American Cancer Society Targeted Therapy Drugs for Chronic Lymphocytic Leukemia — American Cancer Society Ibrutinib (Oral Route) — Mayo Clinic Label: Imbruvica — Ibrutinib Capsule — DailyMed Label: Calquence — Acalabrutinib Tablet, Film Coated — DailyMed Label: Brukinsa — Zanubrutinib Capsule — DailyMed Label: Jaypirca ...
... Your oncologist (cancer doctor) may recommend: Another targeted therapy, such as acalabrutinib (Calquence), pirtobrutinib (Jaypirca), venetoclax (Venclexta) — which is used off-label — or zanubrutinib (Brukinsa) Chimeric antigen receptor (CAR) T-cell therapy, such as brexucabtagene autoleucel (Tecartus) or lisocabtagene maraleucel (Breyanzi) Chemotherapies ...
... Your oncologist (cancer doctor) may recommend: Another targeted therapy, such as acalabrutinib (Calquence), pirtobrutinib (Jaypirca), venetoclax (Venclexta) — which is used off-label — or zanubrutinib (Brukinsa) Chimeric antigen receptor (CAR) T-cell therapy, such as brexucabtagene autoleucel (Tecartus) or lisocabtagene maraleucel (Breyanzi) Chemotherapies ...
... BTK inhibitors approved for use in NHL include: Acalabrutinib (Calquence) Ibrutinib (Imbruvica) Pirtobrutinib (Jaypirca) Zanubrutinib (Brukinsa) Tyrosine Kinase InhibitorsTyrosine kinase inhibitors (TKIs) work by blocking substances that help cancer cells grow. ...
... BTK inhibitors approved for use in NHL include: Acalabrutinib (Calquence) Ibrutinib (Imbruvica) Pirtobrutinib (Jaypirca) Zanubrutinib (Brukinsa) Tyrosine Kinase InhibitorsTyrosine kinase inhibitors (TKIs) work by blocking substances that help cancer cells grow. ...